Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emil M deGoma

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Reviews in Cardiovascular Medicine|July 23, 2014
Lomitapide for the management of homozygous familial hypercholesterolemiaEmil M deGoma
Reviews in Cardiovascular Medicine|October 8, 2014
Correction to "lomitapide for the management of homozygous familial hypercholesterolemia"Emil M deGoma
Current Atherosclerosis Reports|January 10, 2013
Pharmacologic interactions of multidrug therapy for dyslipidemiaNidhi Mehta, Emil M deGoma
Nature Reviews. Cardiology|January 19, 2011
Novel HDL-directed pharmacotherapeutic strategiesEmil M Degoma, Daniel J Rader
The Journal of Clinical Endocrinology and Metabolism|October 9, 2012
Approach to the patient with extremely low HDL-cholesterolDaniel J Rader, Emil M deGoma
Journal of the American College of Cardiology|July 17, 2012
High-density lipoprotein particle number: a better measure to quantify high-density lipoprotein?Emil M deGoma, Daniel J Rader
Annual Review of Medicine|January 16, 2014
Future of cholesteryl ester transfer protein inhibitorsDaniel J Rader, Emil M deGoma
Current Cardiology Reports|September 20, 2012
Targeting high density lipoproteins in the prevention of cardiovascular disease?Daniel B Larach, Emil M deGoma, Daniel J Rader
Journal of Cardiovascular Computed Tomography|November 6, 2010
Guidewire embolization and right ventricular perforation visualized by cardiac CTEmil M deGoma, Neil J Goldberg, Ronald P Karlsberg
Cardiovascular Drugs and Therapy|August 19, 2007
Reinforcing a continuum of care: in-hospital initiation of long-term secondary prevention following acute coronary syndromesStanley G Rockson, Emil M deGoma, Gregg C Fonarow
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Reviews in Cardiovascular Medicine|July 23, 2014
Lomitapide for the management of homozygous familial hypercholesterolemiaEmil M deGoma
Reviews in Cardiovascular Medicine|October 8, 2014
Correction to "lomitapide for the management of homozygous familial hypercholesterolemia"Emil M deGoma
Current Atherosclerosis Reports|January 10, 2013
Pharmacologic interactions of multidrug therapy for dyslipidemiaNidhi Mehta, Emil M deGoma
Nature Reviews. Cardiology|January 19, 2011
Novel HDL-directed pharmacotherapeutic strategiesEmil M Degoma, Daniel J Rader
The Journal of Clinical Endocrinology and Metabolism|October 9, 2012
Approach to the patient with extremely low HDL-cholesterolDaniel J Rader, Emil M deGoma
Journal of the American College of Cardiology|July 17, 2012
High-density lipoprotein particle number: a better measure to quantify high-density lipoprotein?Emil M deGoma, Daniel J Rader
Annual Review of Medicine|January 16, 2014
Future of cholesteryl ester transfer protein inhibitorsDaniel J Rader, Emil M deGoma
Current Cardiology Reports|September 20, 2012
Targeting high density lipoproteins in the prevention of cardiovascular disease?Daniel B Larach, Emil M deGoma, Daniel J Rader
Journal of Cardiovascular Computed Tomography|November 6, 2010
Guidewire embolization and right ventricular perforation visualized by cardiac CTEmil M deGoma, Neil J Goldberg, Ronald P Karlsberg
Cardiovascular Drugs and Therapy|August 19, 2007
Reinforcing a continuum of care: in-hospital initiation of long-term secondary prevention following acute coronary syndromesStanley G Rockson, Emil M deGoma, Gregg C Fonarow
Pageof 4